Company news
Enanta Pharmaceuticals, Inc. news in 2024
Enanta Pharmaceuticals, Inc.'s news releases, calls and decks from 2024, newest first.
Enanta Pharmaceuticals to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit
December 23, 2024
Enanta Pharmaceuticals Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for the Treatment of Respiratory Syncytial Virus (RSV)
December 8, 2024
Enanta Pharmaceuticals to Present Topline Results from First-in-Pediatrics Phase 2 Study Evaluating Zelicapavir for Respiratory Syncytial Virus (RSV)
December 5, 2024
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year-Ended September 30, 2024
November 24, 2024
Enanta Pharmaceuticals Announces Positive Topline Results for EDP-323 in a Phase 2a Human Challenge Study of Healthy Adults Infected With Respiratory Syncytial Virus (RSV)
September 25, 2024
Enanta Pharmaceuticals to Participate in Investor Conferences in September
September 2, 2024
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter
August 4, 2024
Enanta Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference
May 28, 2024
Enanta Pharmaceuticals to Participate at the JMP Securities Life Sciences Conference
May 6, 2024
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Second Quarter with Webcast and Conference Call Today at 4: 30 p.m. ET
May 5, 2024
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
April 29, 2024
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 29, 2024
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
April 28, 2024
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
April 16, 2024
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
March 5, 2024
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2023 with Webcast and Conference Call Today at 4: 30 p.m. ET
February 6, 2024
Enanta Pharmaceuticals to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 5, 2024
Enanta Pharmaceuticals to Host Conference Call on February 7 at 4: 30 p.m. ET to Discuss its Financial Results for its Fiscal First Quarter Ended December 31, 2023
January 30, 2024
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
January 3, 2024
Enanta Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 2, 2024
Calls in 2024
Decks in 2024
- Technical Presentation (December 2024)
Technical · 23 slides · Dec 9, 2024